Literature DB >> 32894455

Hormonal Contraceptives and Dermatology.

Natalie M Williams1, Michael Randolph2, Ali Rajabi-Estarabadi2, Jonette Keri2, Antonella Tosti2.   

Abstract

Hormones play a significant role in normal skin physiology and many dermatologic conditions. As contraceptives and hormonal therapies continue to advance and increase in popularity, it is important for dermatologists to understand their mechanisms and dermatologic effects given the intricate interplay between hormones and the skin. This article reviews the dermatologic effects, both adverse and beneficial, of combined oral contraceptives (COCs), hormonal intrauterine devices (IUDs), implants, injections, and vaginal rings. Overall, the literature suggests that progesterone-only methods, such as implants and hormonal IUDs, tend to trigger or worsen many conditions, including acne, hirsutism, alopecia, and even rosacea. Therefore, it is worthwhile to obtain detailed medication and contraceptive histories on patients with these conditions. There is sufficient evidence that hormonal contraceptives, particularly COCs and vaginal rings, may effectively treat acne and hirsutism. While there are less data to support the role of hormonal contraceptives in other dermatologic disorders, they demonstrate potential in improving androgenetic alopecia and hidradenitis suppurativa.

Entities:  

Mesh:

Substances:

Year:  2021        PMID: 32894455     DOI: 10.1007/s40257-020-00557-5

Source DB:  PubMed          Journal:  Am J Clin Dermatol        ISSN: 1175-0561            Impact factor:   7.403


  117 in total

1.  Inhibition of skin 5 alpha-reductase by oral contraceptive progestins in vitro.

Authors:  T Rabe; A Kowald; J Ortmann; S Rehberger-Schneider
Journal:  Gynecol Endocrinol       Date:  2000-08       Impact factor: 2.260

Review 2.  Evolution of progestins. Focus on the novel progestin drospirenone.

Authors:  Ian H Thorneycroft
Journal:  J Reprod Med       Date:  2002-11       Impact factor: 0.142

3.  Comparing the androgenic and estrogenic properties of progestins used in contraception and hormone therapy.

Authors:  Renate Louw-du Toit; Meghan S Perkins; Janet P Hapgood; Donita Africander
Journal:  Biochem Biophys Res Commun       Date:  2017-07-12       Impact factor: 3.575

4.  Hormonal Contraceptives and Acne: A Retrospective Analysis of 2147 Patients.

Authors:  David Lortscher; Shehla Admani; Nancy Satur; Lawrence F Eichenfield
Journal:  J Drugs Dermatol       Date:  2016-06-01       Impact factor: 2.114

Review 5.  Pathogenesis of acne.

Authors:  M Toyoda; M Morohashi
Journal:  Med Electron Microsc       Date:  2001-03

Review 6.  Acne: hormonal concepts and therapy.

Authors:  Diane Thiboutot
Journal:  Clin Dermatol       Date:  2004 Sep-Oct       Impact factor: 3.541

Review 7.  Progestogens with antiandrogenic properties.

Authors:  Daniel Raudrant; Thomas Rabe
Journal:  Drugs       Date:  2003       Impact factor: 9.546

Review 8.  Hormonal therapy for acne: why not as first line therapy? facts and controversies.

Authors:  Andreas D Katsambas; Clio Dessinioti
Journal:  Clin Dermatol       Date:  2010 Jan-Feb       Impact factor: 3.541

9.  The prevalence of acne in adults 20 years and older.

Authors:  Christin N Collier; Julie C Harper; Jennifer A Cafardi; Wendy C Cantrell; Wenquan Wang; K Wade Foster; Boni E Elewski
Journal:  J Am Acad Dermatol       Date:  2007-10-22       Impact factor: 11.527

Review 10.  The epidemiology of acne vulgaris in late adolescence.

Authors:  Darren D Lynn; Tamara Umari; Cory A Dunnick; Robert P Dellavalle
Journal:  Adolesc Health Med Ther       Date:  2016-01-19
View more
  3 in total

1.  Toxic epidermal necrolysis caused by etonogestrel implantation: A rare presentation.

Authors:  Minorvi Amin; Christopher D Liao; Roger L Simpson
Journal:  JAAD Case Rep       Date:  2022-06-13

2.  Five-Year Remission of Hidradenitis Suppurativa Following the Removal of a Levonorgestrel Intrauterine Device and Disease Overview for Obstetrics and Gynecology Providers.

Authors:  Meredith H Hengy; Rachel Cevigney; Komalpreet Tur; Marlee Hewitt; Mary Ivey
Journal:  Cureus       Date:  2022-09-08

3.  A Cell Membrane-Level Approach to Cicatricial Alopecia Management: Is Caveolin-1 a Viable Therapeutic Target in Frontal Fibrosing Alopecia?

Authors:  Ivan Jozic; Jérémy Chéret; Beatriz Abdo Abujamra; Mariya Miteva; Jennifer Gherardini; Ralf Paus
Journal:  Biomedicines       Date:  2021-05-19
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.